Melagenina Plus, Cuba’s hope against vitiligo, being tested
The drug began to be used in the 1980s. Various formulations were tested until the current version was obtained, which ...
The drug began to be used in the 1980s. Various formulations were tested until the current version was obtained, which ...
Dengue is currently the most important arbovirus that affects humanity and a health problem for Cuba, victim of several epidemics. ...
The drug, developed by the Center for Molecular Immunology, was certified by the Belarusian Healthcare Testing and Expertise Center for ...
Patients with this and other inflammatory and autoimmune diseases could benefit from the novel drug developed by Cuban biotechnology.
The United Nations Development Program (UNDP) in Cuba will implement financing of more than 40 million euros to strengthen the ...
The impact of this crisis on the life of the country has been enormous; especially because the Cuban population, markedly ...
Designed to present the experiences and potential of the Cuban biotechnology and biopharmaceutical sector, BioCubaFarma will have the leading role ...
A multidisciplinary team from the Institute of Tropical Research and Ecological Exchange, from the Florida Keys, concluded in February the ...
The Biotechnological and Pharmaceutical Industries Business Group, known as Biocubafarma, was created just over a year ago. Previously there were ...
OnCuba and the OnCuba logo are registered® trademarks of Fuego Enterprises, Inc., its subsidiaries or divisions.
OnCuba © by Fuego Enterprises, Inc. All Rights Reserved.